The global eye infections treatment market is projected to experience steady growth, with revenues estimated at USD 7.3 billion in 2022 and expected to reach USD 9.9 billion by the end of 2030. This growth is anticipated at a compound annual growth rate (CAGR) of 3.8% from 2022 to 2030, driven by increasing cases of eye infections and advancements in treatment options.
Eye infections, ranging from conjunctivitis to more serious conditions like corneal ulcers, are a significant global health concern. As the prevalence of such infections rises, the demand for effective treatment options, including antibiotics, antifungals, and emerging therapies, is on the rise. Additionally, the aging population and the growing burden of chronic conditions such as diabetes, which increase the risk of eye infections, are further contributing to market expansion.
Key factors driving market growth include technological advancements in diagnostic tools and therapeutic treatments, as well as increased healthcare awareness and improved access to ophthalmic care. Healthcare providers are increasingly focused on offering more personalized and effective solutions to manage eye infections, boosting demand for innovative therapies.
As the eye infections treatment market continues to evolve, pharmaceutical companies are investing in the development of novel treatments, including topical, oral, and injectable formulations. With its growing significance in the ophthalmic care landscape, the market is poised to make substantial contributions to improving global eye health outcomes.
Key Growth Drivers
- Increasing Prevalence of Eye Infections: The rising incidence of various eye infections, including conjunctivitis and keratitis, is driving demand for effective treatments.
- Advancements in Medical Technology: Innovations in ophthalmic formulations and treatment modalities are improving outcomes for patients suffering from eye infections.
- Growing Awareness of Eye Health: Increased public awareness regarding eye health and the importance of timely treatment is contributing to market growth.
Market Dynamics
- Antibiotics Dominance: Antibiotics are expected to account for over 55% of the revenue share in the eye infection treatment market, primarily due to their effectiveness in treating bacterial infections.
- Eye Drops Market Share: Sales of eye drops capture more than 60% of the market share, highlighting their significance in treatment options.
- Hospital and Retail Pharmacy Sales: Hospitals and retail pharmacies collectively generate over 70% of total market revenue.
Competitive Landscape
Eye infections treatment product suppliers are focusing on expanding their market presence across the world by initiating new product launches and boosting sales. Approval for new medications and treatments for eye infections is also expected to be a major trend over the coming years.
- In December 2021, Vuity, a new eye drop medicine was launched for presbyopia which affects millions of people across the world. It was approved by FDA in October and provides a sharper vision for 6 – 10 hours and starts showing effect in 15 minutes of application.
Key Companies Profiled
Allergan plc; Alcon Laboratories Inc.; Bausch Health Companies Inc.; Pfizer Inc.; Akron Pharma Inc; Sanofi S.A.; GlaxoSmithKline plc; Intas Pharmaceuticals Ltd; Johnson & Johnson Services Inc.; Macleods Pharmaceuticals Ltd.; Merck & Co. Inc.; Mylan N.V.; Teva Pharmaceutical Industries Ltd.
Access the Full Report
Key Segments Of Eye Infections Treatment Industry Survey
By Drug Class:
- Antibiotics
- Sulfonamides
- Macrolides
- Erythromycin
- Chloramphenicol
- Aminoglycosides
- Fluoroquinolones
- Vancomycin
- Tetracyclines
- Antivirals
- Thymidine-Based Nucleoside Analogues (Trifluridine)
- Thymidine Phosphorylase Inhibitors (Trifluridine)
- Acyclic Nucleoside Analogue of 2’Deoxyguanasine (Ganciclovir)
- Acyclic Guanine Nucleoside Analog (Acyclovir)
- Others
- Antifungals
- Polyenes (Amphotericin B (AMB) And Natamycin (NTM))
- Azoles (Miconazole (MCZ), Econazole (ECZ) And Ketoconazole (KCZ))
- Pyrimidines
- Echinocandins (Caspofungin (CFG) and Micafungin (MFG))
- Others
- Antihistamines
- Corticosteroids
- Glucocorticoids
By Dosage Form:
- Eye Infections Treatment Tablets
- Eye Infections Treatment Capsules
- Eye Infections Treatment Ophthalmic Ointments
- Eye Infections Treatment Eye Drops
- Others
By Indication:
- Eye Infections Treatment for Conjunctivitis
- Eye Infections Treatment for Keratitis
- Eye Infections Treatment for Endophthalmitis
- Eye Infections Treatment for Blepharitis
- Eye Infections Treatment for Stye or Sty (Hordeolum)
- Eye Infections Treatment for Uveitis
- Eye Infections Treatment for Cellulitis
- Eye Infections Treatment for Ocular Herpes
By Causative Agent:
- Virus
- Bacteria
- Fungus
- Allergens
By Distribution Channels:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
By Region:
- North America Eye Infections Treatment Market
- Latin America Eye Infections Treatment Market
- Europe Eye Infections Treatment Market
- East Asia Eye Infections Treatment Market
- South Asia & Pacific Eye Infections Treatment Market
- Middle East & Africa (MEA) Eye Infections Treatment Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
